Eric Falcand
Directeur Général chez Neopharmed Gentili SpA
Profil
Dr. Eric Falcand is a Chief Executive Officer at Neopharmed Gentili SpA, a General Manager at Servier CJSC and a Vice President, Head-Business Development at Servier Laboratories.
Dr. Falcand was previously employed as an Independent Director by GeNeuro SA (Switzerland), a Head-Business Development & Licensing by Servier Monde SAS, a Head-Sales Division by Synthélabo SA, and a Chief Executive Officer by Servier IP UK Ltd.
He received his graduate degree from the Institut de Pharmacie Industrielle de Lyon, an MBA from EM Lyon Business School and a doctorate degree from Ecole Nationale Vétérinaire de Nantes.
Postes actifs de Eric Falcand
| Sociétés | Poste | Début |
|---|---|---|
Servier CJSC
 Servier CJSC Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases. | Corporate Officer/Principal | - |
Servier Laboratories
 Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | Corporate Officer/Principal | - |
Neopharmed Gentili SpA
 Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | Directeur Général | 07/11/2023 |
Anciens postes connus de Eric Falcand
| Sociétés | Poste | Fin |
|---|---|---|
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Sales & Marketing | 01/01/1997 |
Servier Monde SAS
 Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Servier Monde SAS provides legal services. The company is headquartered in Suresnes, France. | Corporate Officer/Principal | - |
Servier IP UK Ltd.
 Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Directeur Général | - |
| GENEURO SA | Directeur/Membre du Conseil | - |
Formation de Eric Falcand
| EM Lyon Business School | Masters Business Admin |
| Ecole Nationale Vétérinaire de Nantes | Doctorate Degree |
| Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Entreprise privées | 6 |
|---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Health Technology |
Servier Monde SAS
Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Servier Monde SAS provides legal services. The company is headquartered in Suresnes, France. | Commercial Services |
Neopharmed Gentili SpA
Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | Health Technology |
Servier IP UK Ltd.
Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Distribution Services |
Servier Laboratories
Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | Health Technology |
Servier CJSC
Servier CJSC Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases. | Commercial Services |
